FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986267013> ?p ?o ?g. }

• W1986267013 endingPage "57" @default.
• W1986267013 startingPage "46" @default.
• W1986267013 abstract "The mouse skin model of multistage carcinogenesis has demonstrated that cancer results from a synergism between genotoxic and nongenotoxic factors. The former induce irreversible genetic alterations, whereas the latter promote tumor development by favoring the clonal outgrowth of the genetically altered cells. While therapeutic gene repair is a still unrealized dream, tumor promotion provides an attractive target for cancer prevention. Akey event in epithelial tumor development is an aberrant constitutive overexpression of cyclooxygenase-2 (COX-2), being detectable already in premalignant lesions and leading to an overproduction of prostaglandins. In the mouse skin model, prostaglandin F2α has been identified as an endogenous tumor promoter. The well-established chemopreventive effect of nonsteroidal anti-inflammatory drugs seems to be mainly due to COX-2 inhibition. Targeted transgenic overexpression of COX-2 in mouse epidermis induces a preneoplastic phenotype and renders the tissue extremely sensitive to genotoxic carcinogens; i.e., for the induction of skin tumor development, tumor promoter treatment can be omitted in those animals. It is concluded that COX-2 acts as an endogenous tumor promoter and that its overexpression represents a first order risk factor for cancer development. Conversely, specific COX-2 inhibitors rank among the most promising agents for cancer chemoprevention." @default.
• W1986267013 created "2016-06-24" @default.
• W1986267013 creator A5007487924 @default.
• W1986267013 creator A5011536112 @default.
• W1986267013 creator A5080469858 @default.
• W1986267013 creator A5080601032 @default.
• W1986267013 date "2003-01-01" @default.
• W1986267013 modified "2023-10-11" @default.
• W1986267013 title "Mouse Skin as a Model for Cancer Chemoprevention by Nonsteroidal Anti-Inflammatory Drugs" @default.
• W1986267013 cites W113612665 @default.
• W1986267013 cites W1514189093 @default.
• W1986267013 cites W1543714797 @default.
• W1986267013 cites W1558367558 @default.
• W1986267013 cites W1559468817 @default.
• W1986267013 cites W157695109 @default.
• W1986267013 cites W1597512265 @default.
• W1986267013 cites W1895525610 @default.
• W1986267013 cites W1962449772 @default.
• W1986267013 cites W1963797629 @default.
• W1986267013 cites W1990747124 @default.
• W1986267013 cites W1996995529 @default.
• W1986267013 cites W1998232267 @default.
• W1986267013 cites W2003436829 @default.
• W1986267013 cites W2005193096 @default.
• W1986267013 cites W2006307451 @default.
• W1986267013 cites W2009789140 @default.
• W1986267013 cites W2014777348 @default.
• W1986267013 cites W2019667579 @default.
• W1986267013 cites W2033468796 @default.
• W1986267013 cites W2039249065 @default.
• W1986267013 cites W2040528315 @default.
• W1986267013 cites W2042207719 @default.
• W1986267013 cites W2042296424 @default.
• W1986267013 cites W2050888137 @default.
• W1986267013 cites W2051686420 @default.
• W1986267013 cites W2052215025 @default.
• W1986267013 cites W2055619906 @default.
• W1986267013 cites W2062719785 @default.
• W1986267013 cites W2072709583 @default.
• W1986267013 cites W2078386196 @default.
• W1986267013 cites W2083090688 @default.
• W1986267013 cites W2087224686 @default.
• W1986267013 cites W2088404163 @default.
• W1986267013 cites W2088905899 @default.
• W1986267013 cites W2095942707 @default.
• W1986267013 cites W2096952719 @default.
• W1986267013 cites W2109549744 @default.
• W1986267013 cites W2117858791 @default.
• W1986267013 cites W2118972611 @default.
• W1986267013 cites W2125471714 @default.
• W1986267013 cites W2128100003 @default.
• W1986267013 cites W2142849884 @default.
• W1986267013 cites W2145149010 @default.
• W1986267013 cites W2149752901 @default.
• W1986267013 cites W2150586689 @default.
• W1986267013 cites W2150966393 @default.
• W1986267013 cites W2152124429 @default.
• W1986267013 cites W2155952332 @default.
• W1986267013 cites W2156861225 @default.
• W1986267013 cites W2322606352 @default.
• W1986267013 cites W2336160773 @default.
• W1986267013 cites W2336169581 @default.
• W1986267013 cites W2336215030 @default.
• W1986267013 cites W2396709999 @default.
• W1986267013 cites W4206575919 @default.
• W1986267013 cites W4240845666 @default.
• W1986267013 doi "https://doi.org/10.1007/978-3-642-55647-0_5" @default.
• W1986267013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12903842" @default.
• W1986267013 hasPublicationYear "2003" @default.
• W1986267013 type Work @default.
• W1986267013 sameAs 1986267013 @default.
• W1986267013 citedByCount "17" @default.
• W1986267013 countsByYear W19862670132013 @default.
• W1986267013 countsByYear W19862670132014 @default.
• W1986267013 countsByYear W19862670132015 @default.
• W1986267013 countsByYear W19862670132018 @default.
• W1986267013 countsByYear W19862670132021 @default.
• W1986267013 crossrefType "book-chapter" @default.
• W1986267013 hasAuthorship W1986267013A5007487924 @default.
• W1986267013 hasAuthorship W1986267013A5011536112 @default.
• W1986267013 hasAuthorship W1986267013A5080469858 @default.
• W1986267013 hasAuthorship W1986267013A5080601032 @default.
• W1986267013 hasConcept C102230213 @default.
• W1986267013 hasConcept C104317684 @default.
• W1986267013 hasConcept C114246631 @default.
• W1986267013 hasConcept C121608353 @default.
• W1986267013 hasConcept C134018914 @default.
• W1986267013 hasConcept C141035611 @default.
• W1986267013 hasConcept C16613235 @default.
• W1986267013 hasConcept C203014093 @default.
• W1986267013 hasConcept C2777789703 @default.
• W1986267013 hasConcept C2778287671 @default.
• W1986267013 hasConcept C2780122803 @default.
• W1986267013 hasConcept C502942594 @default.
• W1986267013 hasConcept C54355233 @default.
• W1986267013 hasConcept C555283112 @default.
• W1986267013 hasConcept C71924100 @default.
• W1986267013 hasConcept C86803240 @default.

• next